资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Development of a new ARCHITECT automated periostin immunoassay.

Clin. Chim. Acta. 2017-01;

JeanblancNicolette M, HemkenPhilip M, DatwylerMaria J, BrophySusan E, ManetzT Scott, LeeRozanne, LiangMeina, ChowdhuryPartha S, VarkeyReena, GrantEthan P, StreicherKatie, GreenleesLydia, RanadeKoustubh, DavisGera

Products/Services Used	Details	Operation
Codon Optimization	… from the literature [28]. The sequences were submitted to GenScript USA, Inc (Piscataway, NJ) and subjected to their algorithm for optimizing codon usage for maximum expression in human cells. The DNA was synthesized …	Get A Quote

摘要

Periostin is being investigated as a potential biomarker for T-helper-2 (Th2)-driven asthma or eosinophilic inflammation and may help to identify patients more likely to benefit from interleukin-13-targeted treatments. We report the development and analytic performance of the investigational use only ARCHITECT Periostin Immunoassay， a new automated assay developed to detect serum periostin concentrations.